�鶹��Ƶ

The team’s NeuralSAT advanced the frontiers of trustworthy artificial intelligence, earning second place in a highly competitive field of international teams advancing the formal verification of AI systems.

Kun Sun, professor in the Department Information Sciences and Technology, will work with local company CodeLock on software security, supported by the Commonwealth Cyber Initiative's Academic Support for Cybersecurity Entrepreneurship and Next-Gen Development (ASCEND) Fund. 

To predict how a CEO’s compensation may change through the years, you first need to know how corporate boards monitor earnings histories for potential long-term risks.

Led by Associate Professor Jinwei Ye, �鶹��Ƶ’s Imaging and Vision Lab pioneers breakthroughs in computer vision, computational photography, digital content creation, and immersive technologies—offering students hands-on experience with state-of-the-art imaging systems such as a new Light Stage and Pixel Cube.

Two Costello College of Business accounting professors are exploring how inherent personal traits may influence business success—and their early findings will gratify the left-handed among us.

Based on their years of research studying how student-athletes move, �鶹��Ƶ bioengineering professors Parag Chitnis and Siddhartha Sikdar have created a start-up called Myokinetics LLC with the goal of providing personalized rehabilitation programs for injured athletes.

In February, �鶹��Ƶ’s Center for Evidence-Based Crime Policy (CEBCP) within the College of Humanities and Social Sciences, hosted its 12th congressional briefing at the U.S. Capitol, focused on “Preventing Gun Violence.”

One of the most pressing issues in human and ecological health is the abundance of poly and perfluoroalkyl substances (PFAS) and phthalate esters (PAEs) in our ecosystem—two classes of synthetic chemicals known as “forever chemicals.”

Amira Roess shares updated measles information and the implications of the growing number of outbreaks in the U.S. and Mexico.

After nearly three years of backorders and pharmacy scrambles, the high-demand weight-loss drugs Ozempic, Wegovy, and Mounjaro are finally back in full supply. The FDA recently declared an end to the nationwide shortage of their active ingredients, semaglutide and tirzepatide. Martin Binks, chair of the Department of Nutrition and Food Studies at �鶹��Ƶ and a researcher and clinician with expertise in obesity, explains what this moment means for patients, providers, and public health.